Anixa Biosciences treats second patient in ovarian cancer CAR-T trial cohort
Anixa Biosciences said it has treated the second patient in the fifth cohort of its ovarian cancer CAR-T clinical trial.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Anixa Biosciences treats second patient in ovarian cancer CAR-T trial cohort
Anixa Biosciences said it treated the second patient in the fifth cohort of its ovarian cancer CAR-T clinical trial.